FOLH1 and prostate cancer: RM-1 prostate cancer cells expressing human PSMA form tumors in syngeneic B6 mice; however, tumor regression occurs after 14 days in a subset of mice, and subsequent challenge with hPSMA-expressing but not control cells is rejected, suggesting induction of anti-hPSMA immunity.